http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11343289-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07e100d5b5d9a0a35a066a68549daaf9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate | 1998-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0c790dbaa7554c38e59523d3a5f8989 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea89cd5681c168228be2cff6fcd3a120 |
| publicationDate | 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H11343289-A |
| titleOfInvention | N- (imidazo [2,1-a] isoquinolin-9-yl) carbamic acid ester |
| abstract | PROBLEM TO BE SOLVED: To inhibit H + / K + -ATPase activity, inhibit gastric acid secretion, and use Helicobact (Helicobact). a novel imidazo [2,1-a] isoquinoline derivative having an antibacterial activity against er pylori). SOLUTION: General formula (I) [R 1 : lower alkyl or lower alkenyl, Ar; phenyl, pyridyl, furyl or thienyl, R 2 : hydrogen, Represented by lower alkyl, lower alkenyl, amino, lower alkylthio, etc., R 3 ; hydrogen, etc. and R 4 ; hydrogen, etc.] -(Imidazo [2,1-a] isoquinolin-9-yl) Carbamates and pharmaceutically acceptable salts thereof and solvates thereof. |
| priorityDate | 1998-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.